DuPont antibacterial protein partnership targets E.Coli first
date:Sep 21, 2012
tics.

The AvidBiotics Purocin antibacterial technology is based on R-type bacteriocins produced by somePseudomonas aeruginosa strains for their own defense against other bacteria.

These proteins recognise target bacteria by binding to specific receptors on the bacterial surface, punching a hole in the cell envelope and killing it.

Can be developed against any pathogen

In theory, the bacteria can be developed against any pathogen or spoilage organism.

A big advantage of the R-type bacterioci
2/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/13 12:18